Dermalux is a British medical-grade LED phototherapy brand developed by Aesthetic Technology Ltd, a company at the forefront of medical device technologies since 2012. Headquartered in the United Kingdom, Dermalux designs, develops, and manufactures all of its systems domestically, maintaining full ISO 13485 and ISO 9001 certification as a British medical device manufacturer. The brand has established itself as the world-leading and most trusted name in professional LED phototherapy, with a global install base exceeding 10,000 clinical clients and distribution partners spanning more than 40 countries.
Dermalux's product range encompasses professional-grade and at-home LED phototherapy systems. The clinical Dermalux Flex MD is the brand's flagship professional device, offering multi-wavelength LED therapy combining red, near-infrared, and blue light for dermatological and aesthetic treatments. For the consumer market, the Dermalux Flex is a portable, flexible LED device that brings the same multi-wavelength technology into the home setting. Dermalux devices use clinically proven wavelengths to stimulate cellular processes including collagen synthesis, reduce inflammation, and target acne-causing bacteria. The brand's TriWave technology delivers three clinically proven wavelengths in a single treatment session.
Dermalux operates across the professional and luxury consumer beauty technology markets. Professional clinical systems command premium pricing reflective of their medical-grade certification, while the at-home Flex device is positioned in the high luxury consumer segment at approximately $1,950. The brand distributes through a network of international clinical partners, aesthetic practitioners, and dermatology clinics worldwide, alongside direct consumer sales through its e-commerce platform. Dermalux's emphasis on medical-grade manufacturing standards and clinical evidence sets it apart from consumer-oriented LED brands in the market.